The purpose of this legislation is to improve transparency in drug labeling by requiring that labels on pharmaceutical products include detailed information about the original manufacturer and the supply chain. This aims to enhance consumer awareness and accountability regarding the origins of medications. Key provisions of the law mandate that all finished drug products must have labels that display the name, location, and unique identifier of the manufacturer, packer, or distributor.